Ad is loading...
QABGX
Price
$23.57
Change
-$0.17 (-0.72%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

QABGX vs RLEFX

Header iconQABGX vs RLEFX Comparison
Open Charts QABGX vs RLEFXBanner chart's image
Federated Hermes MDT Balanced A
Price$23.57
Change-$0.17 (-0.72%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
QABGX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QABGX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QABGX is a StrongSell and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. QABGX (245M). RLEFX pays higher dividends than QABGX: RLEFX (2.42) vs QABGX (1.32). QABGX was incepted earlier than RLEFX: QABGX (19 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. QABGX (104.00). RLEFX has a lower initial minimum investment than QABGX: RLEFX (250) vs QABGX (1500). QABGX annual gain was more profitable for investors over the last year : 25.51 vs. RLEFX (21.09). RLEFX return over 5 years is better than : 35.95 vs. QABGX (28.93).
QABGXRLEFXQABGX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years9 years-
Gain YTD17.38014.211122%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets245M236B0%
Annual Yield % from dividends1.322.4255%
Returns for 1 year25.5121.09121%
Returns for 3 years-0.3410.95-3%
Returns for 5 years28.9335.9580%
Returns for 10 years55.50N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology